158692-25-2

Basic information

• Product Name: bromo(3,4-methylenedioxyphenyl)-acetic acid methyl ester
• Synonyms: bromo(3,4-methylenedioxyphenyl)-acetic acid methyl ester
• CAS NO: 158692-25-2
• Molecular Weight: 273.083
• Mol File: 158692-25-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: bromo(3,4-methylenedioxyphenyl)-acetic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: bromo(3,4-methylenedioxyphenyl)-acetic acid methyl ester(158692-25-2)
• EPA Substance Registry System: bromo(3,4-methylenedioxyphenyl)-acetic acid methyl ester(158692-25-2)

Safety Data

• Hazardous Substances Data: 158692-25-2(Hazardous Substances Data)

Upstream product

• 2861-28-1 1,3-benzodioxole-5-acetic acid 
• 74-88-4 methyl iodide 

Downstream Products

• 159591-47-6 methyl α-(4-hydroxymethyl-2-n-propyl-phenoxy)-3,4-methylenedioxyphenylacetate 
• 177952-86-2 methyl α-(2-n-propyl-4-cyanophenoxy)-3,4-methylenedioxyphenylacetate 
• 159591-58-9 methyl α-(2-n-propyl-4-aminosulfonyl-phenoxy)-3,4-methylenedioxyphenylacetate 
• 161921-84-2 methyl 2-(2-chloro-4-hydroxymethyl-6-propylphenoxy)-2-(3,4-methylenedioxyphenyl)acetate 
• 158692-26-3 4-(1-carbomethoxy-1-(3,4-methylenedioxy phenyl)methoxy)-3,5-dipropylbenzylalcohol 

Relevant articles and documents

BENZIMIDAZOLINONES SUBSTITUTED WITH PHENOXYPHENYLACETIC ACID DERIVATIVES

Phenoxyphenylacetic acids and derivatives of the general structural formula I STR1 have endothelin antagonist activity and are therefore useful in treating cardiovascular disorders, such as hypertension, pulmonary hypertension, postischemic renal failure, vasospasm, cerebral and cardiac ischemia, myocardial infarction, endotoxic shock, inflammatory diseases including Raynaud's disease and asthma.